Related Experiment Video
Updated: May 8, 2026
08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Pluronic polymer capped biocompatible mesoporous silica nanocarriers
Adem Yildirim1, Gokcen Birlik Demirel, Rengin Erdem
1Institute of Materials Science and Nanotechnology, Bilkent University, 06800 Ankara, Turkey. ademy@bilkent.edu.tr.
Chemical Communications (Cambridge, England)
|September 13, 2013
Summary
Researchers developed PEGylated silica nanocarriers via self-assembly for improved biological applications. These nanocarriers show excellent dispersibility and compatibility in biological settings.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Developing biocompatible nanocarriers is crucial for drug delivery and biomedical applications.
- Silica nanoparticles offer versatile platforms, but surface modification is needed for biological integration.
Purpose of the Study:
- To develop a facile self-assembly method for creating PEGylated silica nanocarriers.
- To evaluate the dispersibility and biocompatibility of the synthesized nanocarriers in biological media.
Main Methods:
- Utilized hydrophobic mesoporous silica nanoparticles.
- Employed Pluronic F127 polymer for self-assembly and surface PEGylation.
- Characterized nanocarrier properties, including dispersibility and compatibility.
Main Results:
- Successfully prepared PEGylated silica nanocarriers through a simple self-assembly process.
- Achieved excellent dispersibility of the nanocarriers in biological media.
- Demonstrated good cytocompatibility and hemocompatibility of the Pluronic-capped nanocarriers.
Conclusions:
- The described self-assembly method provides an efficient route to produce biocompatible PEGylated silica nanocarriers.
- These nanocarriers exhibit favorable properties for potential use in biological and biomedical applications.
